These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 22382030)
1. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Congrains A; Kamide K; Katsuya T; Yasuda O; Oguro R; Yamamoto K; Ohishi M; Rakugi H Biochem Biophys Res Commun; 2012 Mar; 419(4):612-6. PubMed ID: 22382030 [TBL] [Abstract][Full Text] [Related]
2. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423 [TBL] [Abstract][Full Text] [Related]
3. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960 [TBL] [Abstract][Full Text] [Related]
4. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M; J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633 [TBL] [Abstract][Full Text] [Related]
5. ANRIL and atherosclerosis. Chen L; Qu H; Guo M; Zhang Y; Cui Y; Yang Q; Bai R; Shi D J Clin Pharm Ther; 2020 Apr; 45(2):240-248. PubMed ID: 31703157 [TBL] [Abstract][Full Text] [Related]
6. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. Holdt LM; Hoffmann S; Sass K; Langenberger D; Scholz M; Krohn K; Finstermeier K; Stahringer A; Wilfert W; Beutner F; Gielen S; Schuler G; Gäbel G; Bergert H; Bechmann I; Stadler PF; Thiery J; Teupser D PLoS Genet; 2013; 9(7):e1003588. PubMed ID: 23861667 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis. Chi JS; Li JZ; Jia JJ; Zhang T; Liu XM; Yi L J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):816-822. PubMed ID: 29270737 [TBL] [Abstract][Full Text] [Related]
8. [Research advance of ANRIL on atherosclerosis by regulating cell proliferation and apoptosis]. Fang J; Pan Z; Guo X Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):113-117. PubMed ID: 32621415 [TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the 9p21.3 CAD risk locus in Asian Indians. Shanker J; Arvind P; Jambunathan S; Nair J; Kakkar V Thromb Haemost; 2014 May; 111(5):960-9. PubMed ID: 24452806 [TBL] [Abstract][Full Text] [Related]
10. Dysregulation of the Urothelial Cancer Associated 1 Long Noncoding RNA Promotes Proliferation of Vascular Smooth Muscle Cells by Modulating Expression of P27KIP1/CDK2. Zheng HK; Dong MH; Liu GH; An Z; Zhang L; Shan RT; Zhang WQ Genet Test Mol Biomarkers; 2020 Apr; 24(4):204-211. PubMed ID: 32213082 [No Abstract] [Full Text] [Related]
11. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Jarinova O; Stewart AF; Roberts R; Wells G; Lau P; Naing T; Buerki C; McLean BW; Cook RC; Parker JS; McPherson R Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1671-7. PubMed ID: 19592466 [TBL] [Abstract][Full Text] [Related]
12. The Role of ANRIL in Atherosclerosis. Razeghian-Jahromi I; Karimi Akhormeh A; Zibaeenezhad MJ Dis Markers; 2022; 2022():8859677. PubMed ID: 35186169 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA Cho H; Shen GQ; Wang X; Wang F; Archacki S; Li Y; Yu G; Chakrabarti S; Chen Q; Wang QK J Biol Chem; 2019 Mar; 294(11):3881-3898. PubMed ID: 30655286 [TBL] [Abstract][Full Text] [Related]
14. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. Pasmant E; Sabbagh A; Vidaud M; Bièche I FASEB J; 2011 Feb; 25(2):444-8. PubMed ID: 20956613 [TBL] [Abstract][Full Text] [Related]
15. LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a/Sirt1. Tan P; Guo YH; Zhan JK; Long LM; Xu ML; Ye L; Ma XY; Cui XJ; Wang HQ Biochem Cell Biol; 2019 Oct; 97(5):571-580. PubMed ID: 30789795 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA ANRIL inhibits proliferation, migration, and invasion but promotes apoptosis of human glioma cells by upregulation of miR-34a. Dong X; Jin Z; Chen Y; Xu H; Ma C; Hong X; Li Y; Zhao G J Cell Biochem; 2018 Mar; 119(3):2708-2718. PubMed ID: 29057547 [TBL] [Abstract][Full Text] [Related]
17. Long Non-coding RNA-mRNA Correlation Analysis Reveals the Potential Role of HOTAIR in Pathogenesis of Sporadic Thoracic Aortic Aneurysm. Guo X; Chang Q; Pei H; Sun X; Qian X; Tian C; Lin H Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):303-314. PubMed ID: 28757056 [TBL] [Abstract][Full Text] [Related]
18. LncRNA ANRIL regulates cell proliferation and migration via sponging miR-339-5p and regulating FRS2 expression in atherosclerosis. Huang T; Zhao HY; Zhang XB; Gao XL; Peng WP; Zhou Y; Zhao WH; Yang HF Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1956-1969. PubMed ID: 32141564 [TBL] [Abstract][Full Text] [Related]
19. ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Sato K; Nakagawa H; Tajima A; Yoshida K; Inoue I Oncol Rep; 2010 Sep; 24(3):701-7. PubMed ID: 20664976 [TBL] [Abstract][Full Text] [Related]